Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
 shares announced by Shareholders Foundation - EconoTimes)
SAN DIEGO, March 14, 2016 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in Massachusetts on behalf of certain purchasers of shares of PTC Inc (NASDAQ:PTC) over alleged Securities Laws Violations by PTC Inc.
Investors who purchased shares of PTC Inc (NASDAQ:PTC) have certain options and for certain investors are short and strict deadlines running. Deadline: May 6, 2016. NASDAQ:PTC investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff claims that the defendants issued certain allegedly false and misleading statements to investors and/or failed to disclose that PTC Inc did not disclose to the SEC and the DOJ the full results of its investigation into whether PTC China improperly provided recreational travel to Chinese government officials in violation of the FCPA, that PTC Inc was not cooperating with the SEC and the DOJ in connection with their investigations into whether PTC China improperly provided recreational travel to Chinese government officials in violation of the FCPA, that PTC’s books and records were inaccurate and PTC failed to maintain adequate internal accounting controls, and that as a result, PTC’s public statements were materially false and misleading at all relevant times.
On February 16, 2016, PTC Inc announced agreements with the U.S. Securities and Exchange Commission (“SEC”) and the Department of Justice (“DOJ”) that resolve a previously disclosed FCPA investigation pertaining to expenditures by certain former employees and business partners in China between 2006 and 2011. PTC Inc said that in connection with the agreements, PTC and its China subsidiaries will pay $28.2 million in penalties and interest to these agencies.
Shares of PTC Inc (NASDAQ:PTC) declined from $42.25 per share in June 2015 to as low as $27.06 per share on February 8, 2016.
Those who purchased PTC Inc (NASDAQ:PTC) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 [email protected] 3111 Camino Del Rio North Suite 423 San Diego, CA 92108
